|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Nitroprusside#Adult Indications and Dosage]] |
| {{Nitroprusside}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Indications and Usage==
| |
| | |
| Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside can be minimized.
| |
| | |
| Sodium nitroprusside is also indicated for producing controlled [[hypotension]]in order to reduce bleeding during surgery.Sodium nitroprusside is also indicated for the treatment of acute congestive [[heart failure]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NITROPRESS (SODIUM NITROPRUSSIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a44bcac-a0e1-4069-5691-db7b83dbb4b7 | publisher = | date = | accessdate = 27 February 2014 }}</ref>
| |
| | |
| ==References ==
| |
| {{Reflist|2}}
| |
| | |
| {{Nonsympatholytic vasodilatory antihypertensives}}
| |
| | |
| {{DEFAULTSORT:Sodium nitroprusside}}
| |
| [[Category:Cyanides]]
| |
| [[Category:Vasodilators]]
| |
| [[Category:Coordination compounds]]
| |
| [[Category:World Health Organization essential medicines]]
| |
| [[Category:Iron compounds]]
| |
| [[Category:Nitrosyl compounds]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |